Karen Cutler

[Karen Cutler @kccincc]

@DailyLoud Typical. Every dr. I've ever met is like this. I don't use them, don't need anything they offer.

[Karen Cutler @kccincc]

@japan_nobunaga A community note alleges this is fictional. It is actually true, happened after hurricane Wilma in 2005. We were on vacation in Cancun when it struck and blew away the airport, couldn't get back. Then Wilma struck south Florida and closed FLL airport, so couldn't get home.

[Karen Cutler @kccincc]

I live in Florida, no snow but we have hurricanes. We were out of the country for one and couldn't get home for a week because the airports coming and going were blown away. When we did finally arrive home, my car sat in the driveway with the rear window broken and not one neighbor had the decency to throw a tarp over it. So no, not all neighborhoods have the "frontier" spirit.

[Karen Cutler @kccincc]

@LauraLoomer So sorry, I know how you feel. After Wilma blew thru Boca Raton in 2005 we were without electricity for a month.

[Karen Cutler @kccincc]

@SamuraiShibaJP Yes my father served in the 50's. We lived in Fuchu. Japanese people were very nice to us. I will never forget our housekeeper Yoshiko, she was like a mother to me.

[Karen Cutler @kccincc]

@jeremyct Sounds like me, in the 60's, in Florida. But I did something about it - got a second job and went to school part time. Things were better by the 70's.

[Karen Cutler @kccincc]

@FreddyLA7 GO GATORS!!!

[Karen Cutler @kccincc]

@hmoseshill @JonathanTurley Beyond......

[Karen Cutler @kccincc]

@oliverhenry When are you speaking?

[Karen Cutler @kccincc]

@VigilantFox I paid income taxes for 60 years. Now I collect Social Security, which I earned. I pay property taxes on my home which has been paid off for 30 years. I vote. I'm voting against property taxes in November. God bless you Adam.

[Karen Cutler @kccincc]

@paulswaney3 Consider how many tables this waiter has at once. If it's four that would be over $150 an hour in tips. Seems like a lot.

[Karen Cutler @kccincc]

@japan_nobunaga I miss you

[Karen Cutler @kccincc]

@CaryKelly11 I have the Kerrygold unsalted in my fridge right now. The outer package is silver, however the butter inside is wrapped in wax paper. Does this have flourine?

[Karen Cutler @kccincc]

@RudRutherford @MrJohnJnr Takes one to know one Dave

[Karen Cutler @kccincc]

@japan_nobunaga https://t.co/rXG3DRkq56

[Vala Afshar @ValaAfshar]

The very best apology in the history of sports

[Karen Cutler @kccincc]

@JaniceDean Too cute!

[Karen Cutler @kccincc]

@franko_ufo https://t.co/BUwbLzgyn1

[Manifest_Lord @Manifest_Lord]

A cancer surgeon who spent 50 years fighting this disease says 99.9% of oncologists ignore the one cell that actually kills cancer.

He has patients with metastatic pancreatic cancer in complete remission - 5 years out.

Here are 10 things he says everyone needs to understand:

[Karen Cutler @kccincc]

@franko_ufo https://t.co/lM5kSscx4H

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Karen Cutler @kccincc]

@bluelivesmtr @Publix @POTUS When Trump was elected the first time Publix covered his photo on all the magazines at checkout. That's when I stopped shopping there but I would go in occasionally to check. They kept his photo covered for years.

[Karen Cutler @kccincc]

@RapidResponse47 When Trump was elected the first time, Publix covered his picture on all the magazines at checkout. That's when I stopped shopping there. I would go in occasionally to check. They kept his photo covered for years.